Olliaro Piero, Smith Peter G
EDCTP, 2509 AA The Hague, The Netherlands.
J HIV Ther. 2004 Sep;9(3):53-6.
The European and Developing Countries Clinical Trials Partnership (EDCTP) is a new venture between 14 states of the European Union (EU) and Norway to support the conduct of clinical trials of drugs and vaccines (and microbicides) against HIV/AIDS, malaria and tuberculosis in Africa, to develop the capacity to conduct such trials in African institutions, and to promote a more integrated approach to health research amongst European countries. It is funded for 5 years with a contribution of euros 200 million from the European Commission, matched by an equivalent sum that is spent directly by national research programmes of EU member states and Norway on activities that fall under the EDCTP remit. EDCTP seeks to be synergistic with other funding bodies supporting research on these diseases and will promote collaborative research, involving support from multiple funding agencies and harnessing and networking expertise across different African and European countries.
欧洲与发展中国家临床试验合作组织(EDCTP)是欧盟14个成员国与挪威之间的一项新合作项目,旨在支持在非洲开展针对艾滋病毒/艾滋病、疟疾和结核病的药物及疫苗(还有杀微生物剂)临床试验,提升非洲机构开展此类试验的能力,并推动欧洲国家采取更综合的卫生研究方法。该项目由欧盟委员会提供2亿欧元资金,为期5年,欧盟成员国和挪威的国家研究项目也直接投入同等金额用于开展属于EDCTP职权范围内的活动。EDCTP力求与其他支持这些疾病研究的资助机构形成协同效应,并将促进合作研究,包括来自多个资助机构的支持,以及整合不同非洲和欧洲国家的专业知识并建立网络。